直播主题：2024年六月生物医药大事讨论
直播时间：2024年7月7日9:00
直播链接：点击链接观看或微解药APP
各领域专家汇聚在BioSpark Monthly News论坛，交流过去一个月发生的生物医药领域大事件。
本月热点
TOPICS
1. Oncology & Autoimmune Diseases：
T cell therapies for autoimmune diseases;
FDA approved PDE3/4 dual inhibitor ensifentrine for the maintenance therapy of COPD;
AbbVie expands its IBD pipeline with $250M Celsius acquisition;
Bispecific antibody monotherapies vs. monoclonal antibody combo therapies in oncology: Innovent IBI363’s clinical data for several solid tumors;
2. New Modalities:
Alnylam’s Vutrisiran succeeded in phase 3 study of ATTR-CM；
Avidity’s AOC1020 showed positive data from a phase 1/2 trial in facioscapulohumeral muscular dystrophy；
Gilead’s twice-yearly injection of small-molecule lenacapavir as pre-exposure HIV prophylaxis succeeded in phase 3 trial;
3. Other Diseases & Business News:
FDA approved Eli Lilly’s Donanemab for the treatment of early symptomatic Alzheimer’s disease；
Eli Lilly’s tirzepatide phase 3 studies showed reduction of obstructive sleep apnea severity；
Takeda's anti-CD38 antibody on track for phase 3 after boosting platelet count in primary ITP patients；
Novo Nordisk's Ocedurenone failed phase 3 studies in hypertension and chronic kidney disease；
Fosun Pharma offered $692M to privatize Henlius Biotech.
#投资能力大数据# #投资炼金季# #生物医药板块走牛多股大涨# $复星医药(SH600196)$ $诺和诺德(NVO)$ $恒瑞医药(SH600276)$
嘉宾：
Jimmy Wang(王俊), Assistant Professor @ New York University
Yanran He(何嫣然), Investment Director @ Sinopharm-CICC
Ethan Xu(徐亦迅), VP of Bioinformatics @ Aspen Neuroscience
Stephen Yan(严顺飞), BD Search & Evaluation @ AstraZeneca
Leon 'Jun' TANG(唐钧), Founding Partner @ InScienceWeTrust BioAdvisory
Haoran Wang(王浩然), CEO @ Weihai Neoland Biosciences Co.,Ltd.
Xianbo Zhou(周显波), Founder & CEO @ AstraNeura
Charlene Liao(廖晓伶), CEO @ Immune-Onc Therapeutics, Inc.
Xiaowu Chen(陈小五), 副总裁 @ 上海柯君医药科技公司
Shicheng Guo(郭士成), Director of Translational Genetics @ Arrowhead Pharmaceuticals
Sean Yao(姚翔), Co-Founder of Insilico Biosystems
Wenjun Wu(Armstrong,吴文君), Director @ HanKang Venture